Author

K. Iwakiri

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

C. Kawamoto· 1 shared C. Kondo· 1 shared D. Miura· 1 shared H. Harimoto· 1 shared H. Takahashi· 1 shared K. Kaneko· 1 shared K. Nakatsuka· 1 shared M. Atsukawa· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

C. Kawamoto

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivJul 3, 2018

Anti-CD137 monoclonal antibody enhances trastuzumab-induced, natural killer cell-mediated cytotoxicity against pancreatic cancer cell lines with low human epidermal growth factor-like receptor 2 expression

T. Masu, M. Atsukawa, K. Nakatsuka…·K. Iwakiri

This study shows that combining anti-CD137 mAb with trastuzumab enhances NK cell-mediated ADCC against HER2-low pancreatic cancer cells, particularly in individuals with FcγRIIIA-VV/VF genotype.

DOI 10.1371/journal.pone.0200664

humanproteomics

𝕏 PostBluesky